Eleuthero (Eleutherococcus senticosus): A Comprehensive Reference
1. Identity and Botanical Description
Scientific Name and Taxonomy
Eleuthero belongs to the family Araliaceae. Its accepted botanical name is Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. The current authoritative botanical literature refers to it as Eleutherococcus senticosus, and in the Chinese Pharmacopoeia as Acanthopanax senticosus. The Latin name is derived from the Greek eleutheros, meaning "free," kokkos, meaning "pip" or "seed," and the Latin senticosus, meaning "full of briers or thorns." The former Latin name Acanthopanax was also connected with this anatomical feature: it translates as "thorny ginseng."
It may be colloquially called devil's bush, Siberian ginseng, taiga root, eleuthero, ciwujia, devil's shrub, shigoka, touch-me-not, or wild pepper. The use of the name "Siberian Ginseng," and any other commercial use of the word "ginseng" for an herb that is not in the genus Panax, was banned in the United States by the Farm Security and Rural Investment Act of 2002.
Eleuthero (Eleutherococcus senticosus) is also known as Siberian ginseng, but it is not related to true ginseng and has different constituents. It is not the same plant as American ginseng (Panax quinquefolius) or Asian ginseng (Panax ginseng).
Plant Morphology and Habitat
Eleuthero is a species of small, woody shrub native to Northeastern Asia. It is a shrubby plant that grows to about 2.5 m in height, has a woody stem covered with thin thorns, and palmately compound leaves with slender petioles 3–12 cm long, bearing 3–5 leaflets. The herb grows in mixed and coniferous mountain forests, forming low undergrowth or found in groups in thickets and edges. This medicinal plant is widely distributed in Asia, especially in Northeast China, North Japan, and Korea, Southeast Russia, and the Russian Far East.
Roots of E. senticosus are cylindrical, up to 0.5 centimetres in diameter, straight or branched, dark brown, and have a smooth surface with bark fixed closely to the xylem. The genus Eleutherococcus is large, including almost 40 different species. Many Eleutherococcus species grow in Siberia, China, Korea, Japan, and the Philippines; however, E. senticosus is the most well-known and studied species.
Common Preparations and Dosage Forms
Various preparations of E. senticosus root are available, including tincture, liquid and dry hydro-alcoholic extracts (capsules, tablets), teas, and powders. Dietary supplements and teas that contain eleuthero are usually made from the root of the plant. The European Pharmacopoeia specifies quality standards for the dried material. As mentioned in the European Pharmacopoeia monograph of E. senticosus, its dried whole or cut underground organs should contain a minimum of 0.08% for the sum of eleutheroside B and eleutheroside E.
2. Traditional and Historical Use
Traditional Chinese Medicine
Although Cì wǔ jiā (刺五加) has appeared in the Chinese Materia Medica for nearly 2,000 years, the popularity of eleuthero outside of traditional Chinese medicine circles originates from the work of Russian pharmacologists Nikolai Lazarev and Israel Itskovich Brekhman, who gained international renown for their pioneering work in identifying and isolating the most valuable characteristics of plants with adaptogenic properties.
The plant is known as "Siberian ginseng" in North America, Shigoka in Japan, and Ciwujia in China, where it has been widely used to invigorate qi/chi, meaning general energy and vitality. In TCM, eleuthero is used for general weakness and debility, lassitude, anorexia, insomnia, and dream-disturbed sleep. In TCM, it is widely used as a warming and invigorating Qi tonic that supports the spleen, liver, and kidney meridians. It also lives in a category of herbs believed to dispel "wind dampness," which blocks Qi and can cause stagnation.
Russian and Korean Folk Medicine
In traditional Russian medicine, eleuthero is used to stimulate the immune system. The rhizome (Shigoka) is a traditional medicine used as a tonic in northeastern Asia and far eastern Russia. It has also been used in traditional Korean medicine as a tonic and adaptogen to strengthen qi.
Soviet Scientific Interest and the Adaptogen Concept
Eleuthero gained attention when two scientists in the former Soviet Union studied it. Dr. Nikolai Lazarev and Dr. Israel I. Brekhman conducted extensive research on eleuthero's properties during the mid-20th century, and during that time, they coined the now widely used term "adaptogen." Since then, Russian Olympic athletes, astronauts, explorers, divers, sailors, and miners have all used eleuthero to maintain resilience under the stressful conditions they can experience.
The medicinal uses of eleuthero were largely unknown until Panax ginseng, due to overharvesting, became difficult to obtain. At that time, Russian scientists began screening other plants in the Araliaceae family for related compounds. Soviet scientist I. I. Brekhman believed that eleuthero had the same properties as ginseng and popularized it as a less-expensive alternative herb.
Traditional uses for Eleutherococcus are numerous, including fatigue, poor stamina, and stress intolerance, and also nervous and mood disorders such as depression and mental fatigue.
3. Key Constituents and Active Compounds
Eleutherosides
Eleuthero contains eleutherosides — specifically eleutherosides B (syringin) and E (syringaresinol) — that are used to identify Siberian ginseng. The pharmacological effect of E. senticosus is connected with various constituents, among which predominate caffeoylquinic acids, a phenylpropanoid-syringin (eleutheroside B), and syringaresinol derivatives. Two marker compounds, eleutheroside B and eleutheroside E (syringaresinol diglucoside), are used to standardize eleuthero products. In particular, syringin appears as a specific marker for discrimination from other Araliaceae plant materials.
The derived extract from the roots has been characterized for its major constituents, including lignans, sesamin (eleutheroside B4), syringaresinol, phenylpropanes, coumarins, beta-sitosterol, and daucosterol. The root of E. senticosus contains phenolic acids and their derivatives and lignans as major components, as well as coumarins and triterpenoid saponins in lower quantities.
Polysaccharides
Eleuthero contains immune polysaccharides — a group of water-soluble, acidic, branched-chain heteroglycan compounds with high molecular weights — which show significant immune-stimulatory activities as demonstrated by granulocyte and carbon clearance tests and are noted to protect against pathogens and toxins. Researchers increasingly focus on the plant's polysaccharides (often abbreviated ESPS), which appear to contribute to immunomodulatory and anti-fatigue effects in preclinical models.
Other Phytochemicals
Eleuthero's pharmacological potential stems from a variety of bioactive compounds, including eleutherosides, lignans, saponins, flavonoids, and polysaccharides, which contribute to health benefits such as neuroprotective, antidiabetic, anticancer, and antioxidative activities. Berries from E. senticosus contain diverse polyphenols, including caffeic acid, vanillic acid, ferulic acid, p-coumaric acid, and benzoic acid, with significant content of calcium, magnesium, and potassium. Fifty-eight compounds have been identified from E. senticosus root.
4. Mechanisms of Action
Adaptogenic and HPA Axis Modulation
The term "adaptogen" is a functional description rather than a single mechanism: an adaptogen tends to normalize physiological processes under stress without pushing processes in one direction in healthy conditions. It is theorized that eleuthero modulates the hypothalamic-pituitary-adrenal (HPA) axis, which may decrease nitric oxide and cortisol levels. This modulation can help balance immunity, hormones, and stress responses.
Preclinical studies have demonstrated that the adaptogenic action of Eleutherococcus root is a combination of anti-inflammatory and immunomodulatory effects (inhibition of MAPKs, Akt, and NF-κB activation), and neuroprotective activity (increase of brain-derived neurotrophic factor), which may contribute to stress/fatigue reduction and memory-enhancing effects.
Immunomodulatory Mechanisms
Eleuthero activated murine peritoneal macrophages, evidenced by the increase in cytokine mRNA and protein expression, including TNF-α, IL-1β, and IL-6. Furthermore, it boosted nitric oxide production and expression of the inducible nitric oxide synthase gene. Eleuthero activates B cells and macrophages through the Toll-like receptor signaling pathway, as supported by experiments showing that pretreatment of cells with antibodies targeting TLR-4 and TLR-2 significantly attenuated these cellular responses. In contrast, eleuthero did not exert stimulatory effects on T cells.
Both high and low doses of ES polysaccharides were able to considerably boost lymphocyte proliferation at most time periods, raise body weight, antibody titers, and percentages of CD4+ and CD8+ T cells, and increase interferon-gamma and IL-2 levels.
Neuroprotective Mechanisms
BDNF (brain-derived neurotrophic factor) plays an important role in neurogenesis, synapse plasticity, cognitive function, and mood. Administration of an aqueous extract of E. senticosus root variably increased the amount of BDNF mRNA in the hippocampus of rat models. The effect of E. senticosus on regulation of BDNF expression in the hippocampus may justify the antidepressant mechanism of E. senticosus, as well as the effects of memory and concentration improvement.
The mechanism of eleuthero's cognitive effects in animal models is related to increased acetylcholine content and the regulation of enzyme expression, including nitric oxide synthase, superoxide dismutase, and Na+‑K+‑ATPase.
In vivo, E. senticosus root extract at a dose of 20 mg/kg reduced IL-6 and TNF-α secretion in a mouse model of LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway. Research integrating in vitro experiments and molecular docking analyses suggests that E. senticosus extracts may exert a multi-targeted effect in mitigating anxiety and memory deficits associated with Alzheimer's disease, mediated primarily through phosphorylation and activation of the MAPK signaling pathway, with main targets including APP, NTRK1, EGFR, and GSK3B.
5. Scientific Evidence by Area of Use
5.1 Physical Performance and Endurance
In studies on the effects of eleuthero on physical performance under normal and extreme conditions, eleuthero preparation administration was found to lead to improved work capacity, increased physical endurance, reduced recovery times, and increased resistance to fatigue. However, most of this foundational work was conducted in the former Soviet Union and has methodological limitations by modern standards.
One notable human trial examined the effect on aerobic exercise: researchers investigated the effect of Eleutherococcus senticosus Maxim L on performance during submaximal and maximal aerobic exercise. Twenty highly trained distance runners, randomly assigned in matched pairs to either an experimental or placebo group, participated in an 8-week double-blind study completing five trials of a 10-minute treadmill run at their 10 km race pace and a maximal treadmill test. Following a baseline trial, the ESML group consumed 3.4 ml of ESML extract or placebo daily for 6 weeks and were tested every 2 weeks during supplementation and 2 weeks after withdrawal. Heart rate, oxygen consumption, expired minute volume, respiratory exchange ratio, and rating of perceived exertion were measured.
An 8-week study on physically active individuals demonstrated that 800 mg/day (administered as 100 mg capsules, taken multiple times daily) significantly improved physical performance and endurance. Other trials have employed daily doses ranging from 200 to 500 mg of standardized extract. Overall, the evidence for physical performance in humans is mixed and limited by small sample sizes and heterogeneous preparations.
5.2 Immune Function
The most rigorously designed early human trial in this area was a placebo-controlled immunology study: a placebo-controlled study of the effect of an Eleutherococcus senticosus extract (Eleukokk) on the immune system was performed with 36 healthy volunteers utilizing quantitative multi-parameter flow cytometry with monoclonal antibodies directed against specific surface markers of human lymphocyte subpopulations. Volunteers in the verum group received 10 ml of an ethanolic eleuthero preparation, 3 times daily for 4 weeks. The most salient feature in the verum group was a drastic increase in the absolute number of immunocompetent cells, with an especially pronounced effect on T lymphocytes, predominantly of the helper/inducer type, but also on cytotoxic and natural killer cells. A general enhancement of the activation state of T lymphocytes was also observed. No side effects were observed during the trial or during a 6-month observation period afterwards.
In a separate human study, the influence of active components of Eleutherococcus senticosus, contained in the Taiga Wurzel preparation, were studied on cellular defence and physical fitness in 50 healthy volunteers of both sexes. All were randomly subdivided into two study groups: group A with 35 subjects receiving Taiga Wurzel and group B with 15 subjects receiving Echinacea. Twenty healthy males were randomly selected from both groups and underwent an ergospirometric study. The preparations were administered for 30 days: Taiga Wurzel 25 drops three times daily, Echinacea 40 drops three times daily. The study concluded that active components in Eleutherococcus senticosus contained in the Taiga Wurzel preparation affect cellular defence and physical fitness, as well as lipid metabolism.
In small studies, eleuthero has been shown to reduce the severity and length of colds and flu and strengthen the immune system by bolstering T-cells. Overall, the immune evidence is promising but remains preliminary; most mechanistic data come from in vitro and animal studies, and well-powered, reproducible human trials are limited.
5.3 Fatigue and Asthenia
Various preparations of E. senticosus root are available as an adaptogen to reduce fatigue and stress, decrease blood glucose levels, and stimulate the immune system. The European Medicines Agency approved E. senticosus root for the treatment of symptoms of asthenia, such as fatigue and weakness. Preparations of the roots of E. senticosus are given in cases of asthenia with weakness and fatigue, for example, in convalescence. This indication has been officially accepted by the Community Herbal Monograph on Eleutherococcus senticosus (EMEA/HMPC/244569/2006), published by the European Medicines Agency.
Eleutherococcus is indicated in cases of decreased mental and physical capacities such as weakness, exhaustion, fatigue, and loss of concentration, as well as during convalescence, according to ESCOP (European Scientific Cooperative on Phytotherapy) and the EMA (European Medicines Agency). Several clinical studies support these indications.
Among the results analyzed by researchers, some may confirm the efficacy of eleuthero in certain conditions, or at least provide a basis for designing and conducting contemporary clinical trials. Particularly noteworthy are Soviet-era studies on the effects on cognitive function, physical performance, vision, and hearing, as well as the prevention of seasonal diseases, cardiovascular conditions, and effects on pregnancy. Studies on cognitive function have yielded heterogeneous results on cognitive parameters, which appear to be dose-dependent.
5.4 Cognitive Function and Neuroprotection
Eleutheroside B or E, the main components of Acanthopanax, can relieve fatigue, enhance memory, and improve human cognition. An animal study explored this more specifically: researchers replicated a rat model of aging induced by injecting quinolinic acid into the hippocampal CA1 region. These rats were intraperitoneally injected with low, medium, and high doses of eleutheroside B or E (50, 100, 200 mg/kg). At 4 weeks after administration, behavioral tests showed that the escape latencies and errors in searching for the platform in a Morris water maze were dose-dependently reduced in rats treated with medium and high-dose eleutheroside B or E, and the number of surviving hippocampal neurons was greater with milder pathological injury. These are animal data and do not directly translate to confirmed human cognitive benefits.
A previous study showed that the water extract of E. senticosus leaves ameliorated amyloid β(25–35)-induced axonal atrophy using primary cultured neurons. Neuroprotective properties may aid in the management of neurodegenerative conditions such as Alzheimer's and Parkinson's disease, while antidiabetic effects support glucose regulation and insulin sensitivity. These claims remain at the level of preclinical research.
5.5 Herpes Simplex Virus Infections
A double-blind, placebo-controlled, six-month-long study looked at the effects of eleuthero on 93 men and women with recurrent herpes infections, specifically herpes simplex virus type 2 which causes genital herpes. The researchers gave subjects 2 grams of eleuthero root daily. They found that eleuthero decreased the frequency, severity, and duration of herpes outbreaks. A clinical study conducted in men with recurrent genital herpes infections showed that taking a specific Eleutherococcus extract (Elagen), standardized to contain 0.3% eleutherosides, reduces the frequency, severity, and duration of outbreaks. This represents limited but positive clinical evidence in a single trial requiring replication.
5.6 Upper Respiratory Infections
A randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea, and Eleutherococcus senticosus was conducted in patients with upper respiratory tract infections. One registered indication for an eleuthero-containing combination product in Europe is as a herbal medicinal product for the relief of symptoms of cold. Because this evidence involves combination products, the specific contribution of eleuthero is difficult to isolate.
5.7 Preclinical Evidence: Antioxidant, Anti-inflammatory, and Antidiabetic Effects
Eleuthero also exhibits antioxidant, anti-inflammatory, cardioprotective, immunomodulatory, and neuroprotective effects. These properties are largely documented in animal and cell studies. Laboratory and animal studies suggest subtle modulation of the hypothalamic–pituitary–adrenal axis that governs cortisol rhythms; antioxidant and anti-inflammatory actions that may preserve mitochondrial function under load; and support for innate immune activity. No robust human clinical trials have confirmed these effects as standalone outcomes.
6. Regulatory Status and Official Monograph Positions
The European Medicines Agency approved E. senticosus root for the treatment of symptoms of asthenia, such as fatigue and weakness. Eleutherococcus is indicated in cases of decreased mental and physical capacities such as weakness, exhaustion, fatigue, and loss of concentration, as well as during convalescence, according to ESCOP and the EMA.
The German Commission E and the World Health Organization have both published monographs on the herb. The German Commission E monographs recommend a dose of up to 2–3 g of dried and powdered eleuthero root and rhizome daily. The WHO monograph recommends a daily intake of 2–3 g of the raw dried material, which can be consumed as part of a decoction or incorporated into other preparations.
According to the EMA's HMPC monograph, eleuthero is not to be used in children below 12 years. It is not to be used for more than 2–3 months without a break, according to EMA guidance.
7. Dosage Forms and Reported Study Dosages
Various preparations of E. senticosus root include tincture, liquid and dry hydro-alcoholic extracts in capsules or tablets, teas, and powders.
- Producers recommend a daily dose ranging from 0.5 g to 1.5 g of plant material. According to the EMA monograph, a daily dose should be in the range of 0.5–4 g of dried root.
- The German Commission E monographs recommend a dose of up to 2–3 g of dried and powdered eleuthero root and rhizome daily.
- The WHO monograph recommends a daily intake of 2–3 g of the raw dried material.
- An 8-week clinical study on physically active individuals used 800 mg/day, administered as 100 mg capsules taken multiple times daily.
- In one exercise performance trial, subjects consumed 3.4 ml of ESML liquid extract daily for 6 weeks.
- The herpes simplex clinical trial gave subjects 2 grams of eleuthero root daily over 6 months.
- For herpes simplex type 2 infections, a dose of 400 milligrams per day of eleuthero extract standardized to contain 0.3% eleutheroside E has been used in clinical research.
- Typical dosages reported in the literature range from 2 to 3 grams of the whole herb or 300 to 400 milligrams of extract daily.
Clinical studies have used different eleuthero preparations, making it difficult to suggest ideal dosages. Eleuthero supplements typically come in 400–600 mg capsules of root extract.
8. Safety Considerations and Drug Interactions
General Tolerability
According to studies performed primarily in the former Soviet Union, eleuthero appears to present a low order of toxicity in both the short and long term. Human trials have not resulted in any significant side effects, although some reported insomnia, headache, or anxiety. Although eleuthero exhibits a high safety margin in short-term use, particularly when administered in standardized extract form within recommended dosages, its long-term safety and full interaction profile remain under-investigated. This highlights the need for further controlled clinical trials.
Documented Drug Interactions
An important consideration in the clinical use of E. senticosus is its potential to interact with concurrently administered medications. Pharmacokinetic studies have demonstrated that ES preparations may influence the bioavailability and plasma concentrations of certain orally administered drugs. Notably, an interaction with digoxin has been documented, wherein co-administration resulted in a significant increase in serum digoxin levels, likely due to altered gastrointestinal absorption or P-glycoprotein inhibition. Similarly, though less pronounced, interactions have been observed with dexamethasone and diazepam, suggesting modulation of cytochrome P450 enzymes or drug transporters.
One report suggests that eleuthero may alter the results of a test for the medication digoxin. However, it is not clear whether it was the eleuthero or a contaminant that caused these problems. Eleuthero may interfere with blood tests designed to measure digoxin levels.
Due to its immunomodulatory and adaptogenic activity, E. senticosus may theoretically interfere with immunosuppressive treatments or corticosteroids, although this hypothesis has yet to be rigorously evaluated in clinical settings. Individuals on polypharmacy regimens should be monitored closely when using supplements containing eleuthero.
Adulteration
A reported adulterant for eleuthero is Periploca sepium root. A historic adverse event attributed to "Siberian ginseng" was later found to involve not Eleutherococcus, but the bark of the silk vine (Periploca sepium), possibly contaminated with some other unidentified product. This underscores the importance of authentication of raw materials.
Conservation Status
Because of overexploitation of the roots, the species is considered endangered and has been put on the Red List in some countries, for example, the Republic of Korea.
9. Summary of Evidence Quality
The overall body of scientific evidence for eleuthero can be characterized as follows: the herb has strong traditional use across multiple Asian cultures spanning two millennia, regulatory acceptance in Europe (EMA/ESCOP) for asthenia-related indications, and a substantial base of preclinical (animal and in vitro) data supporting adaptogenic, immunomodulatory, and neuroprotective mechanisms. While human trials are mixed, eleuthero remains a popular adaptogenic herb for people looking to sustain mental and physical performance during demanding periods. Studies on cognitive function have yielded heterogeneous results on cognitive parameters, which appear to be dose-dependent. Most human clinical trials are small, of short duration, and use heterogeneous preparations, limiting the conclusions that can be drawn. The immune function data from human flow cytometry studies are among the most consistently positive. Certain studies suggest that eleuthero might help reduce the frequency of herpes outbreaks and could improve immune function, though more rigorous research is needed.
References
Volver